These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


568 related items for PubMed ID: 8855731

  • 1. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
    Katzka DA, Paoletti V, Leite L, Castell DO.
    Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
    [Abstract] [Full Text] [Related]

  • 2. The role of esophageal pH monitoring in symptomatic patients on PPI therapy.
    Charbel S, Khandwala F, Vaezi MF.
    Am J Gastroenterol; 2005 Feb; 100(2):283-9. PubMed ID: 15667483
    [Abstract] [Full Text] [Related]

  • 3. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
    Wo JM, Grist WJ, Gussack G, Delgaudio JM, Waring JP.
    Am J Gastroenterol; 1997 Dec; 92(12):2160-5. PubMed ID: 9399745
    [Abstract] [Full Text] [Related]

  • 4. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy.
    Zerbib F, Roman S, Ropert A, des Varannes SB, Pouderoux P, Chaput U, Mion F, Vérin E, Galmiche JP, Sifrim D.
    Am J Gastroenterol; 2006 Sep; 101(9):1956-63. PubMed ID: 16848801
    [Abstract] [Full Text] [Related]

  • 5. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
    Leite LP, Johnston BT, Just RJ, Castell DO.
    Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
    [Abstract] [Full Text] [Related]

  • 6. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
    Tack J, Koek G, Demedts I, Sifrim D, Janssens J.
    Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
    [Abstract] [Full Text] [Related]

  • 7. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough.
    Ours TM, Kavuru MS, Schilz RJ, Richter JE.
    Am J Gastroenterol; 1999 Nov; 94(11):3131-8. PubMed ID: 10566703
    [Abstract] [Full Text] [Related]

  • 8. 24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors.
    Ortiz A, Martínez de Haro LF, Parrilla P, Molina J, Bermejo J, Munitiz V.
    Br J Surg; 1999 Nov; 86(11):1472-4. PubMed ID: 10583299
    [Abstract] [Full Text] [Related]

  • 9. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus.
    Katzka DA, Castell DO.
    Am J Gastroenterol; 1994 Jul; 89(7):989-91. PubMed ID: 8017396
    [Abstract] [Full Text] [Related]

  • 10. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
    Soto Pérez JC, Icaza ME, Vargas F, Valdovinos Díaz MA.
    Rev Gastroenterol Mex; 2003 Jul; 68(2):113-9. PubMed ID: 15127647
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ, Niezen-de Boer MC, Klinkenberg-Knol EC, Tuynman HA, Voskuil JH, Devillé WL, Meuwissen SG.
    Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
    [Abstract] [Full Text] [Related]

  • 14. Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy.
    Schnatz PF, Castell JA, Castell DO.
    Am J Gastroenterol; 1996 Sep; 91(9):1715-8. PubMed ID: 8792686
    [Abstract] [Full Text] [Related]

  • 15. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD).
    Milkes D, Gerson LB, Triadafilopoulos G.
    Am J Gastroenterol; 2004 Jun; 99(6):991-6. PubMed ID: 15180715
    [Abstract] [Full Text] [Related]

  • 16. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Jun; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 17. Typical GERD symptoms and esophageal pH monitoring are not enough to diagnose pharyngeal reflux.
    Oelschlager BK, Chang L, Pope CE, Pellegrini CA.
    J Surg Res; 2005 Sep; 128(1):55-60. PubMed ID: 16115493
    [Abstract] [Full Text] [Related]

  • 18. Belching: dyspepsia or gastroesophageal reflux disease?
    Lin M, Triadafilopoulos G.
    Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
    [Abstract] [Full Text] [Related]

  • 19. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ, Bredenoord AJ, Weusten BL, Monkelbaan JF, Timmer R, Smout AJ.
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [Abstract] [Full Text] [Related]

  • 20. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
    Omari TI, Haslam RR, Lundborg P, Davidson GP.
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.